Insmed Inc (INSM)vsSeer Inc (SEER)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
SEER
Seer Inc
$1.70
-0.87%
HEALTHCARE · Cap: $94.79M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 3558% more annual revenue ($606.42M vs $16.58M). SEER leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
SEER
Avoid34
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -25.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : SEER
The strongest argument for SEER centers on Price/Book.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : SEER
The primary concerns for SEER are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while SEER is a value play — different risk/reward profiles.
SEER carries more volatility with a beta of 1.66 — expect wider price swings.
SEER is growing revenue faster at 5.0% — sustainability is the question.
SEER generates stronger free cash flow (-11M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 34/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Seer Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Seer, Inc., a life sciences company, is dedicated to developing and marketing products for researchers to unlock biological information. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?